Legal Advantage Investments’s GeneDx Holdings WGS Stock Holding History

Legal Advantage Investments’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.6M	Buy	67,045 +5,370	+9%	+$305K	1.61%	17
2026 Q1	$3.96M	Buy	61,675 +2,025	+3%	+$185K	2.05%	18
2025 Q4	$7.76M	Sell	59,650 -1,000	-2%	-$137K	3.59%	5
2025 Q3	$6.53M	Buy	60,650 +50	+0.1%	+$5.45K	2.94%	9
2025 Q2	$5.59M	Buy	60,600 +10,000	+20%	+$785K	2.62%	12
2025 Q1	$4.48M	Buy	50,600 +16,500	+48%	+$1.43M	2.42%	13
2024 Q4	$2.62M	Sell	34,100 -400	-1%	-$27.9K	1.39%	25
2024 Q3	$1.46M	Buy	34,500 +14,700	+74%	+$496K	0.8%	39
2024 Q2	$518K	Buy	+19,800	New	+$375K	0.3%	70

Other funds holding WGS

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Grange Capital Beaverton, Oregon $108M AUM 18.7% 1-Year Est. Return

Legal Advantage Investments's WGS Position: Q2 2026 in Review

Legal Advantage Investments increased its GeneDx Holdings (WGS) stake by 8.7% in Q2 2026, buying an estimated $305K and bringing the position to 67,045 shares worth $4.6M. The position accounts for 1.61% of the portfolio, ranked #17.

Legal Advantage Investments first reported a position in WGS in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.76M in Q4 2025. 44 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Legal Advantage Investments held 67,045 shares of GeneDx Holdings worth $4.6M as of Q2 2026.
Legal Advantage Investments bought 5,370 GeneDx Holdings shares in Q2 2026, an estimated $305K.
GeneDx Holdings made up 1.61% of Legal Advantage Investments's portfolio in Q2 2026, its #17 holding.
Legal Advantage Investments first reported a position in GeneDx Holdings in Q2 2024 and has held it in 9 quarters since.
Legal Advantage Investments's GeneDx Holdings position peaked at $7.76M in Q4 2025.
44 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.